Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
AXSM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. 0.62%25.0814.1%$147.57m
ICLRICON plc -1.55%251.952.8%$141.91m
HZNPHorizon Therapeutics Plc -0.17%86.425.4%$113.85m
BHCBausch Health Cos., Inc. 0.62%25.080.0%$107.94m
CTLTCatalent, Inc. 0.06%102.082.0%$107.71m
JAZZJazz Pharmaceuticals Plc -1.70%136.762.1%$87.59m
SAVACassava Sciences, Inc. -2.89%36.330.0%$85.54m
UTHRUnited Therapeutics Corp. 0.05%200.0613.9%$78.87m
ZGNXZogenix, Inc. -0.08%25.987.5%$77.91m
PRGOPerrigo Co. Plc -2.27%38.846.9%$49.22m
ARGXargenx SE -0.79%279.250.0%$48.42m
PCRXPacira Biosciences, Inc. -0.89%63.439.8%$28.67m
BRBRBellRing Brands, Inc. 0.29%24.330.0%$26.08m
IRWDIronwood Pharmaceuticals, Inc. 0.64%10.999.5%$22.81m
SAGESAGE Therapeutics, Inc. -1.57%38.217.6%$17.91m

Company Profile

Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.